GlobalData on MSN1d
ElevateBio taps Amazon’s genAI tools to design CRISPR therapeutics
AWS’s framework will speed up the analysis of ElevateBio’s large protein datasets, hinting at promising drug candidates.
ElevateBio Collaborates with AWS to Broaden the Potential of CRISPR Gene Editing Therapies with Generative AI
ElevateBio will leverage artificial intelligence to expand and accelerate CRISPR discovery, design, and drug development for thousands of complex ...
Morningstar3d
ElevateBio Collaborates with AWS to Broaden the Potential of CRISPR Gene Editing Therapies with Generative AI
ElevateBio will leverage artificial intelligence to expand and accelerate CRISPR discovery, design, and drug development for thousands of complex monogenic and polygenic diseases Generative AI ...
Fierce Biotech12d
ElevateBio gene therapy lowers levels of toxic protein in mice with Huntington's disease
ElevateBio is seeking out partnerships for its lead gene therapy after the construct reduced the levels of a toxic protein in ...
ElevateBio Announces Compelling Preclinical Data Demonstrating the Potential of LETI-101 as a Treatment for Huntington's Disease
LETI-101 has demonstrated therapeutically relevant reductions of mutant huntingtin (HTT) protein, exceeding 80%, while preserving essential ...
Panther Life Sciences partners with Pitt BioForge for micro-needle vaccine manufacturing
New York-based Panther Life Sciences Corp. announced a partnership with Pitt BioForge to advance Panther's Microarray Patch ...
Mena FN17d
Elevatebio Announces Compelling Preclinical Data Demonstrating The Potential Of LETI-101 As A Treatment For Huntington's Disease
Feb. 24, 2025 (GLOBE NEWSWIRE) -- ElevateBio, a technology-driven company focused on powering the creation of life-transforming genetic medicines, announced the presentation of new preclinical ...